22 Jan 2025
// GLOBENEWSWIRE
13 Jan 2025
// BUSINESSWIRE
10 Dec 2024
// BUSINESSWIRE
Latest Content by PharmaCompass
Reset all filters
01 1MIRVETUXIMAB SORAVTANSINE-GYNX
Reset all filters
01 1IMMUNOGEN INC
Reset all filters
01 1INJECTABLE;INJECTION
Reset all filters
01 1100mg/20mL single-dose vial
Reset all filters
01 1USA
Regulatory Info :
Registration Country : USA
MIRVETUXIMAB SORAVTANSINE-GYNX
Dosage Form : INJECTABLE;INJECTION
Brand Name : ELAHERE
Dosage Strength : 100mg/20mL single-dose...
Packaging :
Approval Date :
Application Number : 761310
Regulatory Info :
Registration Country : USA